Greenwich LifeSciences (GLSI) Return on Capital Employed Growth (1y) (2021 - 2025)
Greenwich LifeSciences (GLSI) Return on Capital Employed Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 2,400.00 |
| 10 | Greenwich LifeSciences | 184.21 Mn | 184.21 Mn | - | 333,069.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 333,069.00 |
| Sep 30, 2025 | -96,097.00 |
| Jun 30, 2025 | -136,831.00 |
| Mar 31, 2025 | -76,249.00 |
| Dec 31, 2024 | -87,413.00 |
| Sep 30, 2024 | -9,312.00 |
| Jun 30, 2024 | -12,683.00 |
| Mar 31, 2024 | -9,761.00 |
| Dec 31, 2023 | -6,370.00 |
| Sep 30, 2023 | -4,976.00 |
| Jun 30, 2023 | -5,031.00 |
| Mar 31, 2023 | -4,078.00 |
| Dec 31, 2022 | -3,962.00 |
| Sep 30, 2022 | -3,481.00 |
| Jun 30, 2022 | -2,354.00 |
| Mar 31, 2022 | -1,807.00 |
| Dec 31, 2021 | -527.00 |